CA2403574A1 - Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof - Google Patents

Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof Download PDF

Info

Publication number
CA2403574A1
CA2403574A1 CA002403574A CA2403574A CA2403574A1 CA 2403574 A1 CA2403574 A1 CA 2403574A1 CA 002403574 A CA002403574 A CA 002403574A CA 2403574 A CA2403574 A CA 2403574A CA 2403574 A1 CA2403574 A1 CA 2403574A1
Authority
CA
Canada
Prior art keywords
solution
compound
sulphite
container
carbohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002403574A
Other languages
English (en)
French (fr)
Inventor
Torbjorn Linden
Anders Wieslander
Lars-Fride Olsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gambro Lundia AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2403574A1 publication Critical patent/CA2403574A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2027—Separating means having frangible parts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Fluid Mechanics (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bag Frames (AREA)
CA002403574A 2000-05-25 2001-05-18 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof Abandoned CA2403574A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0001939-8 2000-05-25
SE0001939A SE0001939D0 (sv) 2000-05-25 2000-05-25 Medical solution and use thereof
PCT/SE2001/001125 WO2001089478A1 (en) 2000-05-25 2001-05-18 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof

Publications (1)

Publication Number Publication Date
CA2403574A1 true CA2403574A1 (en) 2001-11-29

Family

ID=20279819

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002403574A Abandoned CA2403574A1 (en) 2000-05-25 2001-05-18 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof

Country Status (11)

Country Link
US (1) US20030159953A1 (ko)
EP (1) EP1289496A1 (ko)
JP (1) JP2003534052A (ko)
KR (1) KR20030001486A (ko)
CN (1) CN1190186C (ko)
AU (2) AU6091801A (ko)
BR (1) BR0111095A (ko)
CA (1) CA2403574A1 (ko)
MX (1) MXPA02010839A (ko)
SE (1) SE0001939D0 (ko)
WO (1) WO2001089478A1 (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4882054B2 (ja) 2000-09-13 2012-02-22 独立行政法人科学技術振興機構 腹膜透析液およびその調製法
SE523153C2 (sv) * 2000-12-28 2004-03-30 Gambro Lundia Ab Metod för detoxifiering av medicinsk lösning
DE10134568C2 (de) * 2001-07-16 2003-07-24 Inst Chemo Biosensorik Verfahren zur quantitativen Bestimmung von alpha-Oxoaldehyd
TWI319984B (en) * 2003-06-06 2010-02-01 Sterile combined preparation
SE0400523D0 (sv) 2004-03-01 2004-03-01 Gambro Lundia Ab A medical solution, a method for producing said medical solution and use thereof
US20050276868A1 (en) * 2004-06-10 2005-12-15 Bart Degreve Bicarbonate-based peritoneal dialysis solutions
SE0402507D0 (sv) 2004-10-14 2004-10-14 Gambro Lundia Ab Medicinsk lösning, förfarande för framställning och användning därav
AU2012201932B2 (en) * 2005-01-28 2015-01-22 Fresenius Medical Care Holdings, Inc Systems and methods for delivery of peritoneal dialysis (PD) solutions
US7935070B2 (en) * 2005-01-28 2011-05-03 Fresenius Medical Care North America Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product
US20090187139A1 (en) * 2006-02-08 2009-07-23 Debiotech S.A. Peritoneal dialysis system
US9004761B2 (en) 2006-05-01 2015-04-14 Baxter International Inc. Multiple chamber container with mistake proof administration system
NZ574925A (en) * 2007-07-27 2013-02-22 Fresenius Med Care Hldg Inc Container system for peritoneal dialysis solutions having a first a compartment containing with PD osmotic agent and a second compartment with a PD buffer agent
US9585810B2 (en) 2010-10-14 2017-03-07 Fresenius Medical Care Holdings, Inc. Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser
NO20150142A1 (en) * 2015-01-30 2016-08-01 Pronova Biopharma Norge As Enteral feeding device
KR102657465B1 (ko) * 2021-03-04 2024-04-16 (주) 테크윈 과황산염 용액의 안정화 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4339433A (en) * 1981-01-09 1982-07-13 Baxter Travenol Laboratories, Inc. Additives for peritoneal dialysis solutions
US6306836B1 (en) * 1994-01-21 2001-10-23 Baxter International Inc. Peritoneal dialysis solutions containing maltodextrins and amino acids
SE510030C2 (sv) * 1995-08-08 1999-04-12 Gambro Ab Förfarande för blandning av steril medicinsk lösning samt behållare för utförande av förfarandet

Also Published As

Publication number Publication date
AU6091801A (en) 2001-12-03
EP1289496A1 (en) 2003-03-12
SE0001939D0 (sv) 2000-05-25
JP2003534052A (ja) 2003-11-18
AU2001260918B8 (en) 2005-12-08
KR20030001486A (ko) 2003-01-06
CN1427716A (zh) 2003-07-02
BR0111095A (pt) 2003-04-08
WO2001089478A1 (en) 2001-11-29
MXPA02010839A (es) 2004-02-26
AU2001260918B2 (en) 2005-08-11
CN1190186C (zh) 2005-02-23
US20030159953A1 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
AU2001260918B8 (en) Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof
AU2001260918A1 (en) Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof
EP1465688B9 (en) Bicarbonate-based solutions for dialysis therapies
CA1285528C (en) Preparation of electrolyte solutions and containers
Pitkin et al. Diabetogenic effects of streptozotocin in rhesus monkeys
EP2938187B1 (en) Solution for preserving vascular conduits
CN106794163A (zh) 包含对乙酰氨基酚和布洛芬的水性制剂
WO2011113615A1 (de) Vorrichtung für die peritonealdialyse
CN1679580A (zh) 更昔洛韦注射液及其制备方法
CN106860446A (zh) 小儿复方氨基酸注射液19aa‑i 组合物及降低其氧含量的方法
CN1698595B (zh) 硫普罗宁注射液及其制备方法
EP3212199B1 (en) Pharmaceutical compositions containing steviosides
JP2006000482A (ja) 生体適合性薬液製剤、その製造方法及びその保存方法
DE3877747T2 (de) Glasartige matrize zur verabreichung von heilmitteln.
JP2835402B2 (ja) 有益な剤の投与のための微結晶性マトリックス
CN101239018A (zh) 多层共挤复合膜软袋装肌苷氯化钠注射液组合物及其制法
Collado et al. Effect of pentobarbital or urethane on bile secretion and chemical composition of blood in the rabbit
Rosenthal et al. The relationship between angiography, intraerythrocytic pH and hemoglobin oxygen equilibrium
CN104666334A (zh) 葡萄糖氯化钠钾注射液组合物
CN108928080A (zh) 多层共挤复合膜软袋装肌苷氯化钠注射液组合物及其制法
KR101327904B1 (ko) 목시플록사신 염산염의 주사제형
US20180185492A1 (en) Micro-nano medical adsorbent resin powder material
Moore et al. Kazuyuki Suzuki, Ramesh Khanna, Karl D. Nolph
AU2713788A (en) Microcrystalline matrix for administration of beneficial agent
KR20000032804A (ko) 헤모글로빈의 누출위험이 없는 헤모글로빈-리포좀 시스템

Legal Events

Date Code Title Description
FZDE Discontinued